US Patent Issued to UAB RESEARCH FOUNDATION, ANJI Pharmaceuticals on March 4 for "APOE mimetic peptides and higher potency to clear plasma cholesterol" (Alabama, Massachusetts Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. RE50,320, issued on March 4, was assigned to UAB RESEARCH FOUNDATION (Birmingham, Ala.) and ANJI Pharmaceuticals INC. (Cambridge, Mass.).

"APOE mimetic peptides and higher potency to clear plasma cholesterol" was invented by Gattadahalli M. Anantharamaiah (Birmingham, Ala.) and Dennis Goldberg (Sudbury, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are synthetic apolipoprotein E-mimicking peptides, derivatives thereof, and related peptides, which are useful as therapeutic agents for reducing plasma cholesterol; synthetic methods of making the peptides; pharmaceutical compositions comprising the peptides, and methods of treating lipid and m...